• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估患者对激光预处理以减少糖尿病性黄斑水肿注射负担的接受程度:一项大规模的邮寄调查。

Assessing patient acceptance of laser pretreatment to reduce injection burden in diabetic macular edema: a large scale postal survey.

机构信息

Department of Ophthalmology, Singleton Hospital, Swansea, Wales.

Department of Ophthalmology, Singleton Hospital, Swansea, Wales..

出版信息

Can J Ophthalmol. 2018 Dec;53(6):637-638. doi: 10.1016/j.jcjo.2018.01.034. Epub 2018 Apr 2.

DOI:10.1016/j.jcjo.2018.01.034
PMID:30502991
Abstract

OBJECTIVE

To canvass views about whether argon laser pretreatment to ischemic areas of retina would be acceptable if it resulted in a reduced burden of intravitreal injections.

METHOD

A postal survey was mailed to all 813 patients under the care of the diabetic eye clinic at Singleton Hospital with 10 questions, explanatory information, and a stamp-addressed envelope available for returning completed questionnaires.

RESULTS

Patients were strongly supportive (9.14 out of 10) of the idea of undergoing laser pretreatment if it meant less injections were needed for diabetic macular edema.

CONCLUSION

This is the first time any survey has analyzed patient attitude to laser pretreatment and showed that patients were strongly in favour if it was found to reduce the need for intravitreal injections.

摘要

目的

调查如果氩激光预处理视网膜缺血区可以减少玻璃体腔内注射的负担,患者是否愿意接受。

方法

对Singleton 医院糖尿病眼病诊所的 813 名患者进行了一项邮寄调查,共 10 个问题,附有解释信息和一个贴好邮票的回邮信封,供填写完整的问卷寄回。

结果

如果激光预处理对糖尿病性黄斑水肿意味着需要更少的注射,那么患者非常支持(10 分制 9.14 分)这个想法。

结论

这是第一次对患者对激光预处理的态度进行调查,表明如果发现可以减少玻璃体腔内注射的需要,患者会强烈支持。

相似文献

1
Assessing patient acceptance of laser pretreatment to reduce injection burden in diabetic macular edema: a large scale postal survey.评估患者对激光预处理以减少糖尿病性黄斑水肿注射负担的接受程度:一项大规模的邮寄调查。
Can J Ophthalmol. 2018 Dec;53(6):637-638. doi: 10.1016/j.jcjo.2018.01.034. Epub 2018 Apr 2.
2
Practical Lessons from Protocol I for the Management of Diabetic Macular Edema.《糖尿病性黄斑水肿管理的第一议定书实用经验》
Dev Ophthalmol. 2017;60:91-108. doi: 10.1159/000459692. Epub 2017 Apr 20.
3
Diabetic macular edema.糖尿病性黄斑水肿
Dev Ophthalmol. 2010;47:73-110. doi: 10.1159/000320075. Epub 2010 Aug 10.
4
Intravitreal triamcinolone as an adjunct in the treatment of concomitant proliferative diabetic retinopathy and diffuse diabetic macular oedema. Combined IVTA and laser treatment for PDR with CSMO.玻璃体内注射曲安奈德作为辅助治疗伴增殖性糖尿病视网膜病变和弥漫性糖尿病黄斑水肿。联合玻璃体内注射曲安奈德和激光治疗增殖性糖尿病视网膜病变合并糖尿病性黄斑中心凹水肿。
Int Ophthalmol. 2005 Dec;26(6):207-14. doi: 10.1007/s10792-007-9042-0. Epub 2007 Feb 14.
5
Predictive factors of outcome of selective retina therapy for diabetic macular edema.糖尿病性黄斑水肿选择性视网膜光凝治疗结局的预测因素。
Int Ophthalmol. 2020 May;40(5):1221-1232. doi: 10.1007/s10792-020-01288-6. Epub 2020 Jan 16.
6
Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.玻璃体切除术、玻璃体内注射曲安奈德和黄斑激光光凝三联疗法治疗顽固性糖尿病性黄斑水肿。
Am J Ophthalmol. 2008 Aug;146(2):332-3; author reply 333. doi: 10.1016/j.ajo.2008.04.017.
7
Intravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trial.玻璃体腔内曲安奈德注射预处理糖尿病黄斑水肿激光治疗:一项随机对照临床试验 24 个月结果。
Ophthalmology. 2011 May;118(5):866-72. doi: 10.1016/j.ophtha.2010.09.029. Epub 2011 Jan 12.
8
Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema.玻璃体内注射与眼球后Tenon囊下注射曲安奈德治疗糖尿病性黄斑水肿的比较
Korean J Ophthalmol. 2006 Dec;20(4):205-9. doi: 10.3341/kjo.2006.20.4.205.
9
Diabetic macular edema.糖尿病性黄斑水肿
Ophthalmology. 2012 Dec;119(12):2643.e1. doi: 10.1016/j.ophtha.2012.07.075.
10
Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.对随机接受雷珠单抗或曲安奈德治疗的糖尿病性黄斑水肿(DME)患者的视网膜形态进行详细分析。
Graefes Arch Clin Exp Ophthalmol. 2018 Jan;256(1):49-58. doi: 10.1007/s00417-017-3828-1. Epub 2017 Oct 28.

引用本文的文献

1
Adjunct Nondamaging Focal Laser Reduces Intravitreal Injection Burden in Diabetic Macular Edema.辅助性非损伤性局灶激光减轻糖尿病性黄斑水肿的玻璃体内注射负担
Photonics. 2023 Oct;10(10). doi: 10.3390/photonics10101165. Epub 2023 Oct 18.
2
Perspectives of Patients and Professionals on Implementing a Computer Adaptive Vision-Related Quality of Life Outcome (CAT-EyeQ) in Clinical Practice.患者与专业人士对在临床实践中实施计算机自适应视力相关生活质量结果评估工具(CAT-EyeQ)的看法。
Transl Vis Sci Technol. 2024 Mar 1;13(3):6. doi: 10.1167/tvst.13.3.6.
3
Predictors of vision-related quality of life in patients with macular oedema receiving intra-vitreal anti-VEGF treatment.
接受玻璃体内抗血管内皮生长因子治疗的黄斑水肿患者视力相关生活质量的预测因素。
Ophthalmic Physiol Opt. 2022 Jul;42(4):849-857. doi: 10.1111/opo.12984. Epub 2022 Apr 2.
4
Translation and content validity of the Dutch Impact of Vision Impairment questionnaire assessed by Three-Step Test-Interviewing.通过三步测试访谈评估的荷兰视力损害影响问卷的翻译及内容效度
J Patient Rep Outcomes. 2021 Jan 5;5(1):1. doi: 10.1186/s41687-020-00272-z.